Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer

Conditions

• Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
• Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation
• Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
• Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant
• Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant
• Metastatic Urothelial Carcinoma
• MTAP Negative

Interventions

• DRUG: Avelumab
• DRUG: Pemetrexed

Sponsor

M.D. Anderson Cancer Center

Collaborators

• [object Object]